article thumbnail

Navigating Ad Regulations: Digital Compliance for Pharma Marketers

Pharma Marketing Network

In the ever-evolving digital landscape, pharma marketers must stay up to date with the latest ad regulations. Navigating the complex web of rules and regulations requires careful consideration and preparation. This includes understanding the various laws and regulations that govern digital advertising.

article thumbnail

FDA unveils comprehensive strategy for regulating AI in medical products

BioPharma Reporter

With the pharma and healthcare landscape increasingly being shaped by artificial intelligence (AI), the US Food and Drug Administration (FDA) has taken proactive steps to outline a comprehensive strategy for regulating AI in medical products.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DGFT implements stricter regulations for export of chitin and chitosan derivatives

AuroBlog - Aurous Healthcare Clinical Trials blog

These measures are specifically tailored to ensure regulatory compliance, particularly for exports destined for the EU market, thereby bolstering the reputation of Indian […]

article thumbnail

More federal regulators investigating Biogen's Alzheimer's drug

Bio Pharma Dive

In a regulatory filing, Biogen said the FTC and the SEC are looking for information about Aduhelm's approval and marketing, meaning the drug is now the focus of four government probes.

article thumbnail

Incyte withdraws cancer drug from FDA review after discussions with regulator

Bio Pharma Dive

The decision is a further sign of regulators' scrutiny of accelerated approvals for cancer therapies, an initiative that's led to several market withdrawals.

article thumbnail

FDA Pharmacovigilance Regulations Update

ProRelix Research

The United States Food and Drug Administration (FDA) has strict regulations regarding pharmacovigilance activities that are a part of post-marketing studies for drugs and medical devices that are required as […] The post FDA Pharmacovigilance Regulations Update appeared first on ProRelix Research.

article thumbnail

Lilly CEO reaffirms commitment to Chinese market amid US threat against local biotechs

Fierce Pharma

and China, Eli Lilly’s CEO said the Indianapolis-based company remains committed to the Chinese market. David Ricks’ visit to China comes as Lilly has several key drug applications under review at local regulators. At a time of heightened geopolitical tensions between the U.S.